COSMOS Pharmaceutical Corporation
CSMYF · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $524,194 | $612,493 | $271,243 | $250,361 |
| - Cash | $57,038 | $52,301 | $45,928 | $37,362 |
| + Debt | $49,957 | $34,063 | $18,201 | $9,413 |
| Enterprise Value | $517,113 | $594,255 | $243,516 | $222,412 |
| Revenue | $1,011,390 | $964,989 | $827,697 | $755,414 |
| % Growth | 4.8% | 16.6% | 9.6% | – |
| Gross Profit | $213,281 | $188,306 | $168,718 | $151,448 |
| % Margin | 21.1% | 19.5% | 20.4% | 20% |
| EBITDA | $64,855 | $53,742 | $50,192 | $48,210 |
| % Margin | 6.4% | 5.6% | 6.1% | 6.4% |
| Net Income | $30,978 | $24,454 | $23,797 | $23,155 |
| % Margin | 3.1% | 2.5% | 2.9% | 3.1% |
| EPS Diluted | 390.86 | 308.61 | 600.95 | 584.74 |
| % Growth | 26.7% | -48.6% | 2.8% | – |
| Operating Cash Flow | $52,467 | $55,175 | $54,434 | $32,194 |
| Capital Expenditures | -$53,326 | -$55,810 | -$46,636 | -$43,497 |
| Free Cash Flow | -$859 | -$635 | $7,798 | -$11,303 |